Remove COVID-19 Vaccine Remove FDA Remove Health Care Access Remove Malpractice
article thumbnail

Health Provider News

Hall Render

Health Policy Commission still missing key document in Steward sale to Optum Local obesity drug developer lands deal worth up to $600M with Novo Nordisk Mass. Health Policy Commission still missing key document in Steward sale to Optum Local obesity drug developer lands deal worth up to $600M with Novo Nordisk Mass.

article thumbnail

Health Provider News

Hall Render

The CDC has stopped printing them Telehealth Visits Decline 46%, But Telebehavioral Healthcare Still High URAC to offer health equity accreditation Walgreens CIO is latest to leave in company’s C-suite shakeup AI is creating a complex landscape for healthcare executives ALABAMA Alabama hospital to remain on Cerner after sale Alabama gets $3.6M

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Health Provider News

Hall Render

The CDC has stopped printing them Telehealth Visits Decline 46%, But Telebehavioral Healthcare Still High URAC to offer health equity accreditation Walgreens CIO is latest to leave in company’s C-suite shakeup AI is creating a complex landscape for healthcare executives ALABAMA Alabama hospital to remain on Cerner after sale Alabama gets $3.6M

article thumbnail

Health Provider News

Hall Render

Judge denies challenge to measure that would cap LA hospital exec pay COLORADO Builders show little interest in city, hospital employee housing project Capitol Pain Institute acquires 3 Colorado practices, ASC Colorado lawmakers seek financial information from hospitals in larger debate over health care costs Colorado to advance $1.4

article thumbnail

Health Provider News

Hall Render

Mental health hospital slated for Wichita could solve some problems but faces staffing questions Missouri and Kansas limit payouts in medical malpractice lawsuits. acres from Our Lady of Lourdes for new health sciences center New gene therapies are a near-cure for Louisiana’s sickle cell patients. But who really benefits?